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Brain neurons offer diverse responses to stresses and detrimental factors during
development and aging, and as a result of both neurodegenerative and neuropsychiatric
disorders. This multiplicity of responses can be ascribed to the great diversity among
neuronal populations. Here we have determined the metabolomic profile of three healthy
adult human brain regions—entorhinal cortex, hippocampus, and frontal cortex—using
mass spectrometry-based technologies. Our results show the existence of a lessened
energy demand, mitochondrial stress, and lower one-carbon metabolism (particularly
restricted to the methionine cycle) specifically in frontal cortex. These findings, along
with the better antioxidant capacity and lower mTOR signaling also seen in frontal cortex,
suggest that this brain region is especially resistant to stress compared to the entorhinal
cortex and hippocampus, which are more vulnerable regions. Globally, our results show
the presence of specific metabolomics adaptations in three mature, healthy human brain
regions, confirming the existence of cross-regional differences in cell vulnerability in the
human cerebral cortex.
Keywords: energy metabolism, mammalian target of rapamycin (mTOR), metabolomics, methionine cycle,
mitochondrial stress, nucleotide metabolism, one-carbon metabolism, selective neuronal vulnerability
INTRODUCTION
Human evolution is associated with rapid expansion of brain size and complexity, a prerequisite
for the emergence of cognitive functions. These evolutionary changes have been linked to and
supported by adaptations in brain metabolism, especially with respect to increased energy supply
(Mink et al., 1981; Cáceres et al., 2003; Uddin et al., 2004; Fu et al., 2011; Somel et al., 2013). Thus,
neurons in the human nervous system can perform a wide array of motor, sensory, regulatory,
behavioral, and cognitive functions. This functional diversity is expressed in the central nervous
system (CNS) by a complex organization in different regions that groups neuronal populations
with a diversity of neural cells. The morphological and functional diversity among neurons suggests
that each neuron type, and by extension each brain region, has its own genomic expression profile
in addition to the ‘housekeeping’ genes necessary for the basal function of all cells, which are
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essentially related to cellular metabolism (Lein et al., 2007;
Hawrylycz et al., 2012). This gene expression profile determines a
proteomic pattern which, in turn, configures a regional neuron-
specific metabolomic profile. Because each level of organization
of the ‘-omics’ depends on the other, and a perturbation in
one network can affect another, the phenotypic properties of
different brain regions are ultimately the product of distinctive
combinations of expressed gene products and their regulation,
resulting in the metabolome as the informative modality to define
cellular diversity in the CNS.
The fact that specific regions of the CNS exhibit differential
vulnerabilities to aging and various neurodegenerative (NDD)
and neuropsychiatric diseases (NPD) also reinforces the idea
of the heterogeneity in neuronal responses to cell-damaging
processes, in addition to specificity in the etiology of each
pathology (Mattson and Magnus, 2006; Domínguez et al., 2016).
So, in order to better understand the mechanisms which are
involved in neuronal resistance/sensitivity to stress and death,
it is crucial to define the cell vulnerability of the different brain
regions in physiological conditions.
This study focuses on the prospects that an ‘omic’ approach
offers for the identification of traits that define the selective
neuronal vulnerability (SNV) for a given brain region, and their
potential involvement in the neuronal aging process and the
development of NDD and NPD. To date no metabolomic studies
investigating cross-regional differences in the human brain have
been reported. To overcome this limitation, here we use mass
spectrometry-based technology (ESI-TQ-MS/MS) to measure
the concentrations of 37 specific metabolites of three different
regions of the adult human cerebral cortex.
We designed a panel of metabolites mostly belonging to the
one-carbon metabolism, as an integrative network of nutrient
status and energy metabolism which involves three pathways:
the folate cycle, the methionine cycle, and the trans-sulfuration
pathway (Locasale, 2013). In addition to the metabolomic
analysis, we have also measured, using western blot, different
factors associated with stress resistance and cell survival such as
the antioxidants catalase and SOD1, the FOXO transcriptional
factor FOXO1, the repressor element 1-silencing transcription
factor REST (Lu et al., 2014), and the master regulator that
senses cell nutrient and energy status, the mechanistic target of
rapamycin mTOR (Perluigi et al., 2015).
Using this approach, we studied metabolic differences in three
functionally and evolutionarily distinct brain regions: entorhinal
cortex, hippocampus, and frontal cortex. The frontal cortex is
a brain region that appeared recently during primate evolution
and which is implicated in complex associative functions,
while the entorhinal-hippocampus system functions as a hub
in a widespread network for memory. We also focused on
hippocampus, entorhinal and frontal cortex areas because of their
importance in aging, NDDs such as Alzheimer’s disease (AD),
and NPDs such as schizophrenia. This allowed us to examine how
resistance to stress determines region-specific vulnerability in the
adult human cerebral cortex.
TABLE 1 | Cases examined.
Case Age (y) Gender Post-mortem delay Cause of death Entorhinal cortex
(n = 11)
Hippocampus
(n = 9)
Frontal cortex
(n = 11)
1 43 Male 4 h 35 min Respiratory failure x
2 43 Male 5 h 55 min Multiorgan failure x
3 47 Male 4 h 55 min Cardiac arrest x
4 48 Female 4 h Respiratory failure x
5 50 Male 17 h 15 min Cardiac arrest x
6 52 Male 4 h 04 min Myocardial infarction x
7 52 Male 4 h 40 min Broncho-pneumonia x
8 53 Male 7 h 25 min Heart failure x
9 54 Female 14 h 25 min Bilateral pneumonia x x
10 54 Male 10 h 35 min Pneumonia x x
11 56 Male 3 h 45 min Renal failure x x x
12 56 Male 8 h 50 min Myocardial infarction x x
13 57 Male 20 h 30 min Respiratory failure x x
14 58 Male 3 h 10 min Massive intestinal ischaemia x x
15 58 Male 4 h Respiratory failure x
16 58 Male 8 h 05 min Pneumonia x x
17 59 Male 4 h 15 min Multiorgan failure x x
18 61 Male 3 h 55 min Multiorgan failure x x
19 64 Female 5 h Heart failure x
20 66 Female 4 h 15 min Respiratory failure x x
Mean post-mortem delay (in hours) 9.01 ± 1.81 8.61 ± 1.94 4.76 ± 0.32#
Mean age∗ (in years) 56.36 ± 1.26 57.00 ± 0.76 53.72 ± 2.41
∗Values are expressed as mean ± SEM. Non-significant differences were observed for the variable ‘age’ between regions. Non-significant differences were observed for
‘post-mortem delay’ between regions, with the exception of the comparison entorhinal cortex vs frontal cortex (#p = 0.048).
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SUBJECTS/MATERIALS AND METHODS
Chemicals
Unless otherwise specified, all reagents were from Sigma–
Aldrich, and of the highest purity available.
Human Samples
Brain samples were obtained from the Institute of
Neuropathology Brain Bank following the guidelines of the
local ethics committee, and in accordance with recently
published criteria of sample quality (Ferrer, 2015). The study of
human samples was carried out according to the Spanish Law of
Science and accompanying guidelines and with the approval of
the local ethics committee of the Bellvitge University Hospital
(Barcelona, Spain). The selection of cases examined in the
present study corresponded to a consecutive series of donations
(see Table 1). The brains of adult healthy subjects were obtained
at from 3 to 20 h after death, and were immediately prepared for
morphological and biochemical studies, as previously described
Ferrer et al. (2008).
Briefly, at autopsy, one hemisphere was fixed in 4% buffered
formalin for about 3 weeks while the other hemisphere was cut
in coronal sections 1 cm thick. Selected samples of the brain were
dissected and placed in labeled plastic bags, immediately frozen
on dry ice, and stored at−80◦C until use. The neuropathological
study was carried out on formalin-fixed, paraffin-embedded
samples of the frontal, primary motor, primary sensory, parietal,
temporal superior, temporal inferior, anterior cingulated, anterior
insular, and primary and associative visual cortices; entorhinal
cortex and hippocampus; caudate, putamen, and globus pallidus;
medial and posterior thalamus; subthalamus; Meynert nucleus;
amygdala; midbrain (two levels), pons, and medulla oblongata;
and cerebellar cortex and dentate nucleus. De-waxed sections, 5-
µm thick, were stained with haematoxylin and eosin, and Klü
Barrera or processed for immunohistochemistry to β-amyloid,
phosphorylated tau, α-synuclein, ubiquitin, p62, TDP43, glial
fibrillary protein, and microglia markers.
Selected cases did not show lesions on the neuropathological
examination including any kind of β-amyloid, tau, hypoxic, or
vascular pathology. Following the initial screening, the present
series includes 20 cases: 16 men and 4 women, aged from 43 to
66 years with post-mortem delay ranging from 3 h 10 min to
20 h 30 min (Table 1). Frozen samples of the entorhinal cortex
(n= 11), hippocampus (n= 9), and frontal cortex area 8 (n= 11)
were used for metabolomics and western blot studies. Samples
from the three regions were processed in parallel.
Metabolomic Analysis
An important technical concern is the accuracy of metabolite
measurements made in postmortem brain tissue for in vivo
metabolite concentrations. The criteria applied for the selection
of cases ensure the quality of the samples and the preservation of
the concentration of in vivo metabolites measured. Reinforcing
this, previous studies demonstrated that the concentration of
several metabolites (such as myo-inositol, creatine, glutamine,
glutamate, N-acetylaspartate, taurine, spermine, spermidine,
and putrescine) remained stable in postmortem brain tissue
over long-term intervals (Perry et al., 1981; Petroff et al.,
1988; Michaelis et al., 1996; Chen et al., 2009; Opstad et al.,
2010). Because most of these metabolites belong to metabolic
pathways associated with one-carbon metabolites, we understand
that metabolites analyzed in the present study are stable;
consequently, we excluded postmortem delay as a confounding
factor in the present study.
Metabolite Extraction from Brain Samples
Tissue samples (40 mg) were homogenized in cold methanol
(20 v/w) containing 1 µg/mL of phenylalanine C13 as
internal standard and 1 µM butylhydroxytoluene as antioxidant,
obtaining a final concentration of 50 mg tissue/mL. Then,
samples were incubated at 20◦C for 1 h and centrifuged at
12000 g for 3 min, and the supernatants were subjected to mass
spectrometry analysis.
Triple Quadrupole Mass Spectrometry
For analysis, we have developed a new method (using a targeted
approach based on LC ESI-TQ MS/MS) to detect and quantify
a metabolomic panel including 37 metabolites belonging to
energy metabolism and one-carbon metabolism in human brain
tissue (see Table 2). Samples were decoded and randomized
before injection. Every 5 samples, internal and external standards
were injected as a quality control. Data were finally normalized
according to deuterated internal standard content, and expressed
as MS counts.
Samples were analyzed with liquid chromatography (UPLC
1290, Agilent Technologies, San Jose, CA, USA) coupled with
electrospray ionization on a triple quadrupole mass spectrometer
(ESI-TQ MS/MS, Agilent Technologies 6420, San Jose, CA, USA).
For analysis 6 µL of the extract was injected. Chromatographic
separation was achieved on a reversed phase C18 (2.1 × 50 mm,
1.8 µm particles; Agilent Technologies, San Jose, CA, USA)
column using a flow rate of 0.2 mL/min during a 19 min gradient
(0–5 min 0% B, 5–8 min from 0% B to 30% B, 8–9 min from 30%
B to 100% B, 8–12 min 100% B, 12–13 min from 100% B to 0% B,
13–19 min 0% B), while using the solvents A, 0.1% formic acid,
and B, acetonitril 0.1% formic acid. Electrospray ionization was
performed in both positive and negative ion mode (depending
on the target metabolite) using N2 at a pressure of 50 psi for the
nebulizer with a flow of 12 L/min and a temperature of 325◦C,
respectively.
To detect the individual metabolites, multiple reaction
monitoring (MRM) in negative and in positive ion mode
was performed with individually optimized fragmentor voltage
and collision energies (Optimizer Application, MassHunter,
Agilent Technologies, San Jose, CA, USA). Most of the MRM
parameters were achieved by flow injection of pure standards
and the MassHunter Optimizer software (Agilent Technologies,
San Jose, CA, USA). However, some of metabolites required
manual optimization using MassHunter Qualitative Analyses
(Agilent Technologies, San Jose, CA, USA). All the MRM
parameters obtained from optimization were compared to the
literature when available for certain compounds. Finally, a
chromatographic system was applied to determine retention time
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of each standard. Peak determination and peak area integration
were carried out with MassHunter Qualitative Analyses (Agilent
Technologies, San Jose, CA, USA).
Mass Spectrometry Analysis of 2-SC
2-SC was determined as trifluoroacetic acid methyl ester
(TFAME) derivatives in acid-hydrolysed, delipidated, and
reduced brain protein samples with GC/MS using a HP6890
Series II gas chromatograph (Agilent, Barcelona, Spain) with
an MSD5973A Series detector and a 7683 Series automatic
injector, an HP-5MS column (30 m × 0.25 mm × 0.25 µm),
and the described temperature program (Naudí et al., 2013).
Quantification was performed with internal and external
standardization using standard curves constructed from mixtures
of deuterated and non-deuterated standards. Analyses were
carried out with selected ion-monitoring GC/MS (SIM-GC/MS).
The ions used were lysine and [2H8]lysine, m/z 180 and 187,
respectively, and 2-SC and [2H2]SC, m/z 284 and 286. The
amount of product was expressed as µmoles of 2-SC per mol of
lysine.
Western Blot Analysis
The amounts of different factors associated with stress resistance
and cell survival such as the antioxidants catalase and SOD1,
the FOXO transcriptional factor FOXO1, the repressor element
1-silencing transcription factor REST, and the master regulator
that senses cell nutrient and energy status, mechanistic target of
rapamycin mTOR, were estimated using western blot analyses in
samples from brain tissue.
Brain tissue (50 mg from each specific brain region) was
homogenized in a buffer containing 180 mM KCl, 5 mM MOPS,
2 mM EDTA, 1 mM diethylenetriaminepentaacetic acid, 1 µM
butylated hydroxyltoluene, protease inhibitor mix (80-6501-23,
Amersham Biosciences), and phosphatase inhibitors (Na3VO4
1 mM, NaF 1 mM). A brief centrifugation (1000 rpm at 4◦C for
3 min) to pellet and remove cellular debris was performed. The
protein concentration was measured using the Bradford method
(Bio-Rad Protein Assay 500-0006). Proteins were separated with
one-dimensional SDS-PAGE. Samples were mixed with sample
buffer (62.5 mM Tris–HCl pH 6.8, 2% SDS, 10% glycerol,
20% 2-β-mercaptoethanol and 0.02% bromophenol blue) and
heated at 95◦C for 5 min. Proteins (35 µg) were subjected
to electrophoresis on 10% SDS-polyacrylamide minigels. For
immunodetection, proteins were transferred, using a Mini Trans-
Blot Transfer Cell (Bio Rad) in a buffer containing 25 mM TRIS,
192 mM Glycine, and 20% methanol, to polyvinylidene difluoride
(PVDF) membranes (Immobilon-P Millipore, Bedford, MA,
USA). The membranes were immersed in blocking solution
(0.5% BSA Sigma-Aldrich A4503, 0.1% Tween in TBS) at room
temperature for 1 h. After blocking, the membranes were washed
two times using 0.05% TBS-T buffer. Afterward, they were
incubated in primary solution using specific antibodies: anti-
GFAP (1:1000, ref. ab7260), anti-catalase (1:1000, ref. ab16731),
anti-SOD1 (1:5000, ref. ab52950), anti-FoxO1 (1:1000, ref. 2880
Cell Signaling), anti-REST (1:1000, ref. ab21635), and anti-
phospho-mTOR and anti-mTOR (1:1000 in both cases, ref. 2971s
and 2972-Cell Signaling Technology, respectively). An antibody
to actin (1:5000, ref. A5441 Sigma) was also used in each analysis
to determine the amount of the different factors in reference to
total protein mass. Primary antibody specificity was tested by
incubating only with the secondary antibody.
The primary antibody was incubated at 4◦C for 16 h.
Then, the membrane was washed three times in 0.05% TBS-
T buffer and incubated at room temperature for 1 h with
the appropriate secondary antibodies [ECL Anti-mouse IgG,
horseradish Peroxidase linked whole antibody-NA93IV GE
Healthcare (1:50000) and ImmunoPure Goat Anti-Rabbit IgG
peroxidase conjugated-31460 Pierce Biotechnology (1:100000)].
After five washes with 0.05% TBS-T buffer, bands were visualized
using an enhanced chemiluminescence HRP substrate (Millipore,
Bedford, MA, USA). Signal quantification and recording was
performed with ChemiDoc equipment (Bio-Rad Laboratories,
Inc., Barcelona, Spain). The amounts of the determined factors
were specifically calculated from the ratio of their densitometry
values in reference to the densitometry values of their own actin
content. Ratio of phospho-mTOR to total-mTOR was calculated.
The amounts of REST and GFAP were specifically calculated
from the ratio of their densitometry values in reference to the
densitometry values of their gallyas stain protein.
Statistical Analysis
All statistic calculations were performed using the SPSS software
(SPSS Inc, Chicago, IL, USA). Values were expressed as
means ± standard error of the mean (SEM). Comparisons
between groups were made with ANOVA followed by DMS tests
for paired groups. The minimum level of statistical significance
was set at p< 0.05 in all the analyses.
RESULTS
Evidence from comparative studies of gene expression and
evolution between humans and anthropoid primate species
suggests that neurons from human neocortex are characterized
by high energy metabolism, along with an increase in neuroglial
cell density in order to support greater metabolic demands
(Sherwood et al., 2006). We have extended this idea to three
different regions of the adult human brain cerebral cortex to
evaluate possible differences in the density of glial cells relative to
neurons, as an indirect indication of region-specific adaptation
to neuronal metabolic demands. Our results demonstrate that
frontal cortex shows an increased density of neurons along with a
concomitant decrease in glial cells compared to entorhinal cortex
(p< 0.01 and p< 0.05, respectively) and hippocampus (p< 0.05
and p< 0.01, respectively) (Figure 1), suggesting lower neuronal
metabolic demands specifically in frontal cortex.
To explore the bioenergetic demands of the different
regions of the human cerebral cortex, we measured, using
a TQMS approach, a myriad of metabolites which directly
(succinate and fumarate) or indirectly (leucine, tryptophan,
glutamate, glutamine, proline, carnitine, and glyceraldehyde-
3-phosphate) are associated with or involved in Krebs cycle
(Figure 2). No interregional differences were detected for leucine,
tryptophan, carnitine, glutamate, or glutamine. In contrast, the
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FIGURE 1 | Content of neurons and glial cells in different regions of the adult human cerebral cortex. N-acetyl-Asp-Glu was used as a marker for neuronal
content, and myoinositol and GFAP as markers for glial cell content. N-acetyl-Asp-Glu and myoinositol were determined with TQMS, while GFAP was measured with
western blot. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. a, significant differences with respect to entorhinal cortex; b, significant differences with respect to hippocampus.
FIGURE 2 | Concentrations of metabolites involved in bioenergetics metabolism in different regions of the adult human cerebral cortex. Metabolites
were detected and quantified with TQMS. The steady-state level of 2-SC was measured with GC-MS. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. a, significant
differences with respect to entorhinal cortex; b, significant differences with respect to hippocampus.
concentrations of succinate and fumarate, and of proline, were
significantly lower in frontal cortex compared to entorhinal
cortex and hippocampus, while no differences were observed
between entorhinal cortex and hippocampus.
Since mitochondria play a key role in cell bioenergetics, we
detected and measured 2-SC as a biomarker of mitochondrial
stress in order to test for potential cross-regional differences.
2-SC [S-(2-succino)cysteine] is a chemical modification
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FIGURE 3 | Tissue concentrations of metabolites from the serine, glycine and threonine metabolism in different regions of the adult human cerebral
cortex. All metabolites were measured with TQMS. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. a, significant differences with respect to entorhinal cortex; b, significant
differences with respect to hippocampus.
of cysteine in proteins by the Krebs cycle intermediate,
fumarate, via a succination reaction. Recent studies suggest
that succination is a mechanistic link between mitochondrial
dysfunction, oxidative and ER stress, and cellular progression
toward apoptosis (Merkley et al., 2014). Our results show
that the steady-state levels of 2-SC are significantly lower
in frontal cortex compared to entorhinal cortex, with no
differences between entorhinal cortex and hippocampus
(Figure 2).
Cell physiology requires the biosynthesis of a diversity of
cellular components (including proteins, lipids, and nucleic
acids), as well the maintenance of cell redox status, and genetic
and epigenetic status. Amino acid metabolism involving serine
and glycine, and the carbon units that they provide, covers
many of these requirements. Figure 3 demonstrates the existence
of significant inter-regional differences in the concentrations
of serine, glycine, and threonine, and related metabolites such
as choline, betaine, and sarcosine, thereby verifying that the
concentrations of all these metabolites are significantly lower
in frontal cortex, and higher in hippocampus, compared to
entorhinal cortex.
We then investigated interregional differences of one-
carbon metabolism in human cerebral cortex. In particular,
we focused our analysis on metabolites belonging to the
methionine metabolism (including the methionine cycle
and the trans-sulfuration pathway) and purine metabolism.
To assess these pathways, we measured, with TQMS, the
metabolites (directly or closely related to) that follow: (a) for
methionine cycle: methionine, S-adenosyl-methionine, and
homocysteine, as well as spermidine and proline; (b) for the
trans-sulfuration pathway: cystationine, cysteine, gluthatione,
taurine, and vitamin B6 (pyridoxal and pyridoxamine); and
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FIGURE 4 | Tissue concentrations of metabolites belonging to the methionine metabolism, including the methionine cycle and the trans-sulfuration
pathway, in different regions of the adult human cerebral cortex. All metabolites were measured with TQMS. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. a,
significant differences with respect to entorhinal cortex; b, significant differences with respect to hippocampus.
finally, (c) for purine metabolism: inosine monophosphate
(IMP), adenosine monophosphate (AMP), guanosine
monophosphate (GMP), adenosine, inosine, xanthosine,
deoxyguanosine, hypoxanthine, and xanthine, and we included
the metabolite from pentose phosphate pathway ribose-5-
phosphate. TQMS analysis showed a marked decrease in the
concentration of all metabolites of the methionine cycle in
frontal cortex with respect to hippocampus and/or entorhinal
cortex, while significantly higher concentrations of SAM and
spermidine in hippocampus compared to entorhinal cortex
were detected (Figure 4). No interregional changes were
detected for metabolites of the trans-sulfuration pathway, with
the exception of taurine, which was significantly higher in
hippocampus compared to entorhinal cortex, and again lower
in frontal cortex compared to hippocampus (Figure 4). No
interregional differences were detected for the metabolites of
the purine metabolism, with the exception of xanthosine and
hypoxhantine, which were significantly lower in frontal cortex
(Figure 5).
We then considered whether this interregionally differing
metabolic status might be associated with changes in cellular
systems linked to stress resistance and cell survival. To
this end, we measured the antioxidant enzymes catalase
and SOD1, the FOXO transcriptional factor FOXO1, the
repressor element 1-silencing transcription factor REST, and
the master regulator that senses cell nutrient and energy
status, mechanistic target of rapamycin mTOR (Figure 6).
Western blot analysis showed that catalase and SOD1 were
significantly and specifically increased in frontal cortex, that
FOXO1 and REST did not show interregional differences, and
that the activation of mTOR was significantly lower in frontal
cortex.
DISCUSSION
Although metabolic pathways important to brain function
are conserved across diverse taxa (Peregrín-Alvarez et al.,
2009), current findings show that brain metabolism experienced
relevant changes in the human species (Somel et al., 2013).
In addition to evolutionary considerations, brain neurons offer
a diverse response to stresses during the physiological aging
process or as a result of both NDD and NPD (Mattson
and Magnus, 2006; Jové et al., 2014; Naudí et al., 2015).
The morphological and functional diversity among neuronal
cells, the temporal trajectory of functional losses during
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FIGURE 5 | Tissue concentrations of metabolites from the purine metabolism in different regions of the adult human cerebral cortex. All metabolites
were measured with TQMS. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. a, significant differences with respect to entorhinal cortex; b, significant differences with respect to
hippocampus.
the aging process, and the temporal pattern and specificity
in the appearance and development of each NDD and
NPD, as well as the heterogeneity in neuronal responses to
detrimental processes associated with each of the pathologies,
all confirm the existence of a cross-regional SNV (Mattson
and Magnus, 2006; Jové et al., 2014; Naudí et al., 2015). This
SNV could be expressed through a neuron(region)-specific
metabolomic profile. Hence, metabolomics can help to define
and improve understanding of cellular (regional) diversity
in the CNS. From an inter-regional comparative perspective
there is, however, a lack of studies focused on outlining
the specific metabolomics of the distinctly functional sub-
regions of the brain. To shed light on this, we performed
a comparative metabolomic analysis of three healthy human
brain regions: entorhinal cortex, hippocampus, and frontal
cortex.
Our results show the existence of reduced energy demand,
mitochondrial stress, and one-carbon metabolism (particularly
restricted to the methionine cycle) specifically in frontal cortex.
These findings, along with a better antioxidant capacity and
lower mTOR signaling as well in frontal cortex, suggest that
this brain region is especially resistant to stress compared to the
entorhinal cortex and hippocampus, which are more vulnerable
regions.
The one-carbon metabolism can be considered as an
integrative network of nutrient status. Thus, inputs in the
form of amino acids (which donate carbon units) enter the
metabolic network, are metabolized, and then become output
for diverse biological functions which include biosynthesis
of cell components, regulation of redox status, regulation of
methylation reactions, and regulation of nucleotide pools. The
partitioning of carbon units into these different cellular outputs
basically involves three interconnected pathways: the folate
cycle, the methionine cycle, and the trans-sulfuration pathway
(Locasale, 2013). Several studies have shown that defects in one-
carbon metabolism in brain induce deep disturbances in cell
physiology as a consequence of the relevant pathways where
one-carbon metabolism is involved, and also, more importantly,
through the toxic effects derived from the metabolites which
shape the core of the methionine cycle. Thus, a connection
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FIGURE 6 | Tissue protein expression of factors associated with stress resistance and cell survival in different regions of the adult human cerebral
cortex. The antioxidants catalase and SOD1, the FOXO transcriptional factor FOXO1, the repressor element 1-silencing transcription factor REST, and the master
regulator that senses cell nutrient and energy status, mechanistic target of rapamycin mTOR, where all determined with western blot. ∗p < 0.05; ∗∗p < 0.01;
∗∗∗p < 0.001. a, significant differences with respect to entorhinal cortex; b, significant differences with respect to hippocampus. All western blots can be found as
Supplementary Figure S1.
has been established between high levels of homocysteine and
cognitive function, from mild cognitive decline to vascular
dementia and AD (Miller, 2003). In contrast, low methionine
and derived metabolite content, either constitutively or induced
by nutritional intervention, is associated with resistance to
stress and a longer lifespan (Pamplona and Barja, 2006,
2011; Naudí et al., 2007). Hence, we may infer that the
lower one-carbon metabolism observed in frontal cortex is a
physiological adaptation which confers resistance to stress on this
region.
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mTOR is a conserved serine/threonine kinase which regulates
metabolism in response to nutrients, growth factors, and cellular
energy conditions. Available evidence indicates that the mTOR
signaling pathway is involved in brain aging and age-related
NDD diseases (Garelick and Kennedy, 2011; Bockaert and Marin,
2015; Perluigi et al., 2015). In this line, an increasing number
of studies show that disruption in mTOR signaling in the brain
affects multiple pathways including glucose metabolism, energy
production, mitochondrial function, and autophagy. Conversely,
attenuation of the mTOR signal, through pharmacological or
nutritional intervention, increases longevity and is associated
with a healthy lifespan, including improvement in brain function
(Garelick and Kennedy, 2011; Perluigi et al., 2015). Consequently,
we may infer that the lower mTOR signaling observed in frontal
cortex is a physiological adaptation which confers resistance to
stress on this region.
CONCLUSION
Our results define the existence of metabolomic differences
in three different regions of the mature, healthy human
brain, confirming the existence of cross-regional differences in
the brain. We must note, however, that although our study
covers key cellular metabolic pathways, it is far from being
comprehensive. Nevertheless, our findings indicate that the
metabolomic signature is an optimized feature associated with
diversity among neuronal populations in brain cortex, allowing
us to hypothesize that the metabolic optimization of some
physiological traits, such as resistance to stress, is region-specific.
However, it is evident that more studies are needed to draw a
metabolomic-wide atlas of metabolites in the adult human brain.
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